Comparison of Single- and Double-Level Radiofrequency Ablation for Chronic Coccydynia
RecruitingNot applicableNCT07509593
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aims to compare two commonly used radiofrequency ablation (RFA) techniques for the treatment of chronic tailbone (coccyx) pain, also known as coccydynia. Chronic coccydynia can significantly impair daily activities and reduce quality of life, particularly in patients who do not respond adequately to conservative treatments. Participants in this study will be randomly assigned to receive either a single-level or double-level radiofrequency ablation (RFA) procedure targeting the coccygeal nerve pathways. These procedures are minimally invasive and are routinely performed in pain management practice. The primary objective of the study is to determine which technique provides superior pain relief and functional improvement. Patients will be followed for up to two months after the procedure, and pain intensity and quality of life will be evaluated using validated outcome measures. The results of this study may help optimize interventional treatment strategies for patients suffering from chronic coccydynia.
Study details
- Official title
- Comparison of Single- and Double-Level Radiofrequency Ablation for Chronic Coccydynia
- Conditions
- Chronic Coccydynia
- Interventions
- Procedure: Single-Level Ganglion Impar Radiofrequency Ablation
- Procedure: Double-Level Ganglion Impar Radiofrequency Ablation
- Sponsor
- Marmara University
- Start date
- 2026-06-01
- Primary completion
- 2027-06
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with coccygeal pain lasting longer than 2 months * Patients who experienced significant pain relief (≥50% reduction) after a ganglion impar block performed within the last 6 months, but whose pain has subsequently recurred * Patients who provide informed consent to participate in the study Exclusion Criteria: * Acute coccydynia (pain duration less than 2 months) * Patients who did not achieve significant benefit (\<50% pain reduction) from prior ganglion impar block * Patients with severe neurological or psychiatric disorders that impair communication or ability to follow instructions
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07509593